Administration of estradiol metabolites for the treatment or prevention of obesity, metabolic syndrome, diabetes, and vascular and renal disorders
Details for Australian Patent Application No. 2002331618 (hide)
International Classifications
Event Publications
6 February 2003 Complete Application Filed
Priority application(s): 60/312,741 17.08.01 US
29 May 2003 Application Open to Public Inspection
Published as AU-B-2002331618
1 November 2007 Application Accepted
Published as AU-B-2002331618
28 February 2008 Standard Patent Sealed
18 March 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2002331619-METHOD FOR CHARACTERIZING AUTOIMMUNE DISORDERS
2002331617-SYSTEMS AND METHOD FOR PRESENTING CUSTOMIZABLE MULTIMEDIA
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser